Skip to main content

 9WQ6 | pdb_00009wq6

5-HT2AR bound to IHCH-1906 obtained by cryo-electron microscopy (cryoEM)


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.40 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation 3D Report Full Report

Validation slider image for 9WQ6

This is version 1.1 of the entry. See complete history. 

Literature

Structure-based design of subtype-selective psychedelic analogs.

Li, H., Tang, L., Zhang, J., Meng, B., Cao, D., Chen, Y., Yu, J., Wang, H., Liu, Z.J., Wang, S., Cheng, J.

(2026) Nat Commun 17

  • DOI: https://doi.org/10.1038/s41467-026-77658-y
  • Primary Citation Related Structures: 
    9WPQ, 9WPX, 9WQ5, 9WQ6, 9WQA, 9WQB

  • PubMed Abstract: 

    Classical psychedelics exert hallucinogenic and therapeutic effects primarily through activation of serotonin 2 A receptor (5-HT 2A R), offering promise as transformative treatments for neuropsychiatric disorders. However, their concurrent activation of 5-HT 2B R-associated with cardiac valvulopathy-raises serious safety concerns, underscoring the need for subtype-selective psychedelics. To address this, we determine the cryo-EM structure of 5-HT 2A R and perform a comparative structural analysis of the orthosteric binding pockets (OBPs) of 5-HT 2A R and 5-HT 2B R. Guided by key residue differences, we develop a trigonal pharmacophore model to inform the design of 5-HT 2A R-selective agonists that avoid 5-HT 2B R activation. Using this model, we design and synthesize two compound series that selectively activate 5-HT 2A R while antagonizing 5-HT 2B R. Molecular basis of subtype selectivity is confirmed by five additional cryo-EM structures of receptor-ligand complexes. Selected compounds also exhibit antidepressant-like efficacy in animal models. Our findings provide a strategy for the development of safer, subtype-selective psychedelic analogs with therapeutic potential.


  • Organizational Affiliation: 
    • iHuman Institute, ShanghaiTech University, Shanghai, China.

Macromolecule Content 

  • Total Structure Weight: 38.52 kDa 
  • Atom Count: 1,964 
  • Modeled Residue Count: 261 
  • Deposited Residue Count: 339 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
5-hydroxytryptamine receptor 2A339Homo sapiensMutation(s): 0 
Gene Names: HTR2A, HTR2
UniProt & NIH Common Fund Data Resources
Find proteins for P28223 (Homo sapiens)
Explore P28223 
Go to UniProtKB:  P28223
PHAROS:  P28223
GTEx:  ENSG00000102468 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP28223
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1EYE
(Subject of Investigation/LOI)

Query on A1EYE



Download:Ideal Coordinates CCD File
B [auth A]1-(1,2,3,6-tetrahydropyridin-4-yl)-6,7,8,9-tetrahydro-5~{H}-benzo[7]annulen-4-ol
C16 H21 N O
ZGCNFQWWIAVUGL-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.40 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
EM Software:
TaskSoftware PackageVersion
MODEL REFINEMENTPHENIX
RECONSTRUCTIONPHENIX

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Natural Science Foundation of China (NSFC)China--

Revision History  (Full details and data files)

  • Version 1.0: 2026-09-16
    Type: Initial release
  • Version 1.1: 2026-09-30
    Changes: Data collection, Database references